Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 252

1.

Use of the Nijmegen Questionnaire in asthma.

van Dixhoorn J, Folgering H.

ERJ Open Res. 2015 Jul 16;1(1). pii: 00037-2015. eCollection 2015 May.

2.

The Nijmegen Questionnaire and dysfunctional breathing.

van Dixhoorn J, Folgering H.

ERJ Open Res. 2015 May 15;1(1). pii: 00001-2015. eCollection 2015 May.

3.

Metabolic acidosis improves airway conductance in patients with asthma.

Brijker F, van den Elshout FJ, Bosch FH, Heijdra YF, Folgering HT.

J Asthma. 2009 Sep;46(7):656-8. doi: 10.1080/02770900902963110.

PMID:
19728200
4.

Respiratory muscle strength and muscle endurance are not affected by acute metabolic acidemia.

Nizet TA, Heijdra YF, van den Elshout FJ, van de Ven MJ, Bosch FH, Mulder PH, Folgering HT.

Clin Physiol Funct Imaging. 2009 Nov;29(6):392-9. doi: 10.1111/j.1475-097X.2009.00878.x. Epub 2009 Jul 10.

PMID:
19624691
5.

An Integral assessment framework of health status in chronic obstructive pulmonary disease (COPD).

Vercoulen JH, Daudey L, Molema J, Vos PJ, Peters JB, Top M, Folgering H.

Int J Behav Med. 2008;15(4):263-79. doi: 10.1080/10705500802365474.

PMID:
19005926
6.

Are asymptomatic airway hyperresponsiveness and allergy risk factors for asthma? A longitudinal study.

van den Nieuwenhof L, Schermer T, Heijdra Y, Bottema B, Akkermans R, Folgering H, van Weel C.

Eur Respir J. 2008 Jul;32(1):70-6. doi: 10.1183/09031936.00088007. Epub 2008 Apr 2.

7.

Early intervention with inhaled corticosteroids in subjects with rapid decline in lung function and signs of bronchial hyperresponsiveness: results from the DIMCA programme.

den Otter JJ, van Schayck CP, Folgering HT, van den Boom G, Akkermans RP, van Weel C.

Eur J Gen Pract. 2007;13(2):89-91.

PMID:
17534745
8.

Occupational health and general practice: from opportunities lost to opportunities capitalised?

van Weel C, Orbon K, van der Gulden J, Buijs P, Folgering H, Thoonen B, Schermer T.

Med Lav. 2006 Mar-Apr;97(2):288-94.

PMID:
17017361
9.

Exercise performance improves in patients with COPD due to respiratory muscle endurance training.

Koppers RJ, Vos PJ, Boot CR, Folgering HT.

Chest. 2006 Apr;129(4):886-92.

PMID:
16608934
10.

Vocational and working career of asthmatic adolescents is only slightly affected.

Orbon KH, van der Gulden JW, Schermer TR, van den Nieuwenhof L, Boot CR, van den Hoogen H, van Weel C, Folgering HT.

Respir Med. 2006 Jul;100(7):1163-73. Epub 2005 Dec 9.

11.

Impact of a maximal exercise test on symptoms and activity in chronic fatigue syndrome.

Bazelmans E, Bleijenberg G, Voeten MJ, van der Meer JW, Folgering H.

J Psychosom Res. 2005 Oct;59(4):201-8.

PMID:
16223622
12.

Knowledge about asthma and COPD: associations with sick leave, health complaints, functional limitations, adaptation, and perceived control.

Boot CR, van der Gulden JW, Vercoulen JH, van den Borne BH, Orbon KH, Rooijackers J, van Weel C, Folgering HT.

Patient Educ Couns. 2005 Oct;59(1):103-9.

PMID:
16198224
13.

Tube breathing as a new potential method to perform respiratory muscle training: safety in healthy volunteers.

Koppers RJ, Vos PJ, Folgering HT.

Respir Med. 2006 Apr;100(4):714-20. Epub 2005 Aug 29.

14.

Sick leave in workers with asthma and COPD: the role of attitudes, perceived social norms and self efficacy.

Boot CR, Vercoulen JH, van der Gulden JW, van den Borne BH, Orbon KH, van Weel C, Folgering HT.

Patient Educ Couns. 2005 Aug;58(2):192-8.

PMID:
16009296
15.

Predictors of changes in sick leave in workers with asthma: a follow-up study.

Boot CR, Vercoulen JH, van der Gulden JW, Orbon KH, Rooijackers JM, van Weel C, Folgering HT.

Int Arch Occup Environ Health. 2005 Sep;78(8):633-40. Epub 2005 Oct 12.

PMID:
16001208
16.

Bronchial challenge, assessed with forced expiratory manoeuvres and airway impedance.

Broeders ME, Molema J, Hop WC, Folgering HT.

Respir Med. 2005 Aug;99(8):1046-52. Epub 2005 Feb 24.

17.

Sick leave in patients with obstructive lung disease is related to psychosocial and work variables rather than to FEV1.

Boot CR, Vercoulen JH, van der Gulden JW, Orbon KH, van den Hoogen H, Folgering HT.

Respir Med. 2005 Aug;99(8):1022-31. Epub 2005 Mar 21.

18.

Survival of chronic hypercapnic COPD patients is predicted by smoking habits, comorbidity, and hypoxemia.

Nizet TA, van den Elshout FJ, Heijdra YF, van de Ven MJ, Mulder PG, Folgering HT.

Chest. 2005 Jun;127(6):1904-10.

PMID:
15947301
19.

Flow-volumes indices as means to discriminate between intra- and extrapulmonary restrictive disease.

Zanen P, Folgering H, Lammers JW.

Respir Med. 2005 Jul;99(7):825-9. Epub 2005 Jan 25.

20.

Employment status and quality of life in patients with chronic obstructive pulmonary disease.

Orbon KH, Schermer TR, van der Gulden JW, Chavannes NH, Akkermans RP, Schayck OP, van Weel C, Folgering HT.

Int Arch Occup Environ Health. 2005 Jul;78(6):467-74. Epub 2005 May 13.

PMID:
15895242
21.

Ventolin Diskus and Inspyril Turbuhaler: an in vitro comparison.

Broeders ME, Molema J, Burnell PK, Folgering HT.

J Aerosol Med. 2005 Spring;18(1):74-82.

PMID:
15741776
22.

Salbutamol pMDI gives less protection to methacholine induced airway obstruction than salbutamol via spacer or DPI.

Broeders ME, Molema J, Hop WC, Folgering HT.

Eur J Clin Pharmacol. 2005 Feb;60(12):837-41. Epub 2004 Dec 30.

PMID:
15625613
23.

The course of inhalation profiles during an exacerbation of obstructive lung disease.

Broeders ME, Molema J, Hop WC, Vermue NA, Folgering HT.

Respir Med. 2004 Dec;98(12):1173-9.

24.

Tremor side effects of salbutamol, quantified by a laser pointer technique.

Nizet TA, Broeders ME, Folgering HT.

Respir Med. 2004 Sep;98(9):844-50.

25.

Asthma and chronic obstructive pulmonary disease: differences between workers with and without sick leave.

Boot CR, van der Gulden JW, Orbon KH, Vercoulen JH, Akkermans R, van Weel C, Folgering HT.

Int Arch Occup Environ Health. 2004 Jun;77(5):357-62. Epub 2004 Apr 24.

PMID:
15108002
26.

The effect of varied fractional inspired oxygen on arm exercise performance in spinal cord injury and able-bodied persons.

Hopman MT, Houtman S, Groothuis JT, Folgering HT.

Arch Phys Med Rehabil. 2004 Feb;85(2):319-23.

PMID:
14966720
27.

Face mask spirometry and respiratory pressures in normal subjects.

Wohlgemuth M, van der Kooi EL, Hendriks JC, Padberg GW, Folgering HT.

Eur Respir J. 2003 Dec;22(6):1001-6.

28.

Cerebrovascular response to acute metabolic acidosis in humans.

van de Ven M, Colier WN, Kersten BT, Oeseburg B, Folgering H.

Adv Exp Med Biol. 2003;530:707-15.

PMID:
14562769
29.

Validity of spirometric testing in a general practice population of patients with chronic obstructive pulmonary disease (COPD).

Schermer TR, Jacobs JE, Chavannes NH, Hartman J, Folgering HT, Bottema BJ, van Weel C.

Thorax. 2003 Oct;58(10):861-6.

30.

Does the inhalation device affect the bronchodilatory dose response curve of salbutamol in asthma and chronic obstructive pulmonary disease patients?

Broeders ME, Molema J, Hop WC, Vermue NA, Folgering HT.

Eur J Clin Pharmacol. 2003 Sep;59(5-6):449-55. Epub 2003 Aug 12.

PMID:
12920494
31.

The effect of inspired oxygen fraction on peak oxygen uptake during arm exercise.

Hopman MT, Folgering HT, Groothuis JT, Houtman S.

Eur J Appl Physiol. 2003 Sep;90(1-2):120-4. Epub 2003 Jun 24.

PMID:
12827365
32.

Inhalation profiles in asthmatics and COPD patients: reproducibility and effect of instruction.

Broeders ME, Molema J, Hop WC, Folgering HT.

J Aerosol Med. 2003 Summer;16(2):131-41.

PMID:
12823907
33.

Comparison of acetazolamide and medroxyprogesterone as respiratory stimulants in hypercapnic patients with COPD.

Wagenaar M, Vos P, Heijdra Y, Teppema L, Folgering H.

Chest. 2003 May;123(5):1450-9.

PMID:
12740260
34.

Baroreflex and chemoreflex function after bilateral carotid body tumor resection.

Timmers HJ, Karemaker JM, Wieling W, Marres HA, Folgering HT, Lenders JW.

J Hypertens. 2003 Mar;21(3):591-9.

PMID:
12640254
35.

Eccentric exercise training in patients with chronic obstructive pulmonary disease.

Rooyackers JM, Berkeljon DA, Folgering HT.

Int J Rehabil Res. 2003 Mar;26(1):47-9.

PMID:
12601267
36.

In Check Dial: accuracy for Diskus and Turbuhaler.

Broeders ME, Molema J, Vermue NA, Folgering HT.

Int J Pharm. 2003 Feb 18;252(1-2):275-80.

PMID:
12550805
37.

Self-management of asthma in general practice, asthma control and quality of life: a randomised controlled trial.

Thoonen BP, Schermer TR, Van Den Boom G, Molema J, Folgering H, Akkermans RP, Grol R, Van Weel C, Van Schayck CP.

Thorax. 2003 Jan;58(1):30-6.

38.

Combined treatment with acetazolamide and medroxyprogesterone in chronic obstructive pulmonary disease patients.

Wagenaar M, Vos PJ, Heijdra YF, Teppema LJ, Folgering HT.

Eur Respir J. 2002 Nov;20(5):1130-7.

39.

Influence of unequal ventilation on the single breath K(CO) in COPD revealed by comparison with the rebreathing K(CO).

Jansons H, Fokkens JK, Tweel van der I, Lammers JW, Folgering H.

Respir Physiol Neurobiol. 2002 Oct 23;133(1-2):109-19.

PMID:
12385736
40.

Randomized controlled economic evaluation of asthma self-management in primary health care.

Schermer TR, Thoonen BP, van den Boom G, Akkermans RP, Grol RP, Folgering HT, van Weel C, van Schayck CP.

Am J Respir Crit Care Med. 2002 Oct 15;166(8):1062-72.

PMID:
12379549
41.

Guidelines for mechanical lung function measurements in psychophysiology.

Ritz T, Dahme B, Dubois AB, Folgering H, Fritz GK, Harver A, Kotses H, Lehrer PM, Ring C, Steptoe A, Van de Woestijne KP.

Psychophysiology. 2002 Sep;39(5):546-67. Review.

PMID:
12236321
42.

Influence of two different inhalation devices on therapy compliance in asthmatic patients.

van Schayck CP, Bijl-Hofland ID, Folgering H, Cloosterman SG, Akkermans R, van den Elshout F, van Weel C.

Scand J Prim Health Care. 2002 Jun;20(2):126-8.

PMID:
12184713
43.

Arterial baroreflex and peripheral chemoreflex function after radiotherapy for laryngeal or pharyngeal cancer.

Timmers HJ, Karemaker JM, Wieling W, Kaanders JH, Folgering HT, Marres HA, Lenders JW.

Int J Radiat Oncol Biol Phys. 2002 Aug 1;53(5):1203-10.

PMID:
12128121
45.

Potential masking effect on dyspnoea perception by short- and long-acting beta2-agonists in asthma.

van Schayck CP, Bijl-Hofland ID, Cloosterman SG, Folgering HT, van der Elshout FJ, Van Weel C.

Eur Respir J. 2002 Feb;19(2):240-5.

46.

Physical activity and exercise performance in symptomatic Cambodia veterans.

de Vries M, Soetekouw PM, Van Der Meer JW, Folgering H, Bleijenberg G.

QJM. 2002 Feb;95(2):99-105.

PMID:
11861957
47.

Effects of acetazolamide and furosemide on ventilation and cerebral blood volume in normocapnic and hypercapnic patients with COPD.

van de Ven MJ, Colier WN, van der Sluijs MC, Oeseburg B, Vis P, Folgering H.

Chest. 2002 Feb;121(2):383-92.

PMID:
11834647
48.

Discontinuation of furosemide decreases PaCO(2) in patients with COPD.

Brijker F, Heijdra YF, van den Elshout FJ, Folgering HT.

Chest. 2002 Feb;121(2):377-82.

PMID:
11834646
49.

Peak inspiratory flow rate and slope of the inhalation profiles in dry powder inhalers.

Broeders ME, Molema J, Vermue NA, Folgering HT.

Eur Respir J. 2001 Nov;18(5):780-3.

50.

Resistivities of placebo and active Diskus inhalers compared.

Broeders ME, Molema J, Folgering HT.

Int J Pharm. 2001 Oct 9;228(1-2):219-22.

PMID:
11576784

Supplemental Content

Loading ...
Support Center